Dr. Reddy's Laboratories Ltd. (DRREDDY): Dr. Reddy's Laboratories Share Price Rises 3.38% as It Clears Large Cap Threshold

Dr. Reddy's Laboratories Ltd. traded at Rs 1,196.50, up 3.38% today, taking market capitalisation to Rs 97,824 crore and placing the stock among notable large-cap gainers.

Dr. Reddy's Share Price traded at Rs 1,196.50 on 11 August 2026, up Rs 39.15 or 3.38% from the previous close of Rs 1,157.35, lifting the company's market capitalisation to Rs 97,824 crore. That move is notable because the stock sits in the Large Cap category and crossed its qualifying price-rise threshold of 3%, putting it in focus in today's Stock Market Today and Share Market Today screens.

The verified data confirms the price event clearly: the stock opened at Rs 1,160.95, moved through a day low of Rs 1,155.20, and climbed to an intraday high of Rs 1,197.55 before trading near Rs 1,196.50 around the event timestamp. That pattern shows steady upward price action through the session rather than a marginal move around the previous close. In Univest's reading, this is what turned Dr. Reddy's Share Price Today into a stock-specific market update worth tracking.

Why is the stock rising, and why is it trending? The supplied figures establish the rise, the turnover of Rs 4.54 crore on BSE, and total traded volume of 18,85,051 shares across exchanges, but they do not establish a company-specific catalyst. Even so, the scale of the move matters because the gain cleared the exact large-cap qualifying bar and placed the company among top gainer discussions and Stocks in News screens.

The important numbers investors may monitor next are straightforward: whether Dr. Reddy's Share Price holds near the day high, how total volume compares with future sessions, and how this large-cap move sits against the broader Healthcare sector snapshot and listed peers covered below by Univest.

Dr. Reddy's Laboratories Ltd. (DRREDDY) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,196.5
Previous Close	Rs 1,157.35
Today's Change	+Rs 39.15 (+3.38%)
Day Open	Rs 1,160.95
Day High	Rs 1,197.55
Day Low	Rs 1,155.2
Current Volume (BSE)	37,946
BSE Traded Volume	37,946
NSE Traded Volume	18,47,105
Combined NSE + BSE Volume	18,85,051
Turnover	Rs 4.54 crore
Market Capitalisation	Rs 97,824 crore
Market Cap Category	Large Cap

Dr. Reddy's Laboratories Ltd. (DRREDDY) traded at Rs 1,196.5. versus the previous close of Rs 1,157.35, a rise of 3.38%. The stock opened at Rs 1,160.95, reached Rs 1,197.55, touched Rs 1,155.2. Reported volume was 37,946.

Dr. Reddy's Laboratories Ltd. (DRREDDY) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 97,824 crore

Dr. Reddy's Fundamental Analysis is necessarily centred on the verified metrics supplied for the company and the wider market context. The first anchor is size: with a market capitalisation of Rs 97,824 crore, Dr. Reddy's Laboratories is many times larger than the median and average company in the supplied Healthcare benchmark set. Market capitalisation does not say whether a stock is cheap or expensive on its own, but it does establish that this is a large, liquid, institutionally relevant name rather than a thinly traded small-cap counter.

That point becomes clearer when set against the Healthcare benchmark data. The benchmark scope is the same sector, with 197 companies in the market-cap sample. Within that set, the median market capitalisation is Rs 142.30 crore and the average is Rs 472.15 crore, while the maximum shown is Rs 3,032.97 crore. Dr. Reddy's market capitalisation of Rs 97,824 crore stands far above every one of those reference points. So, even before looking at price movement, the company sits in a very different size bracket from most of the benchmark universe.

Because no company-specific P/E ratio, P/B ratio, EV/EBITDA, ROE, ROCE, EPS, book value, dividend yield, debt-to-equity, revenue, profit, margin or cash-flow figures are supplied here, the most reliable fundamental takeaway is not a valuation call but a context call. Investors tracking Dr. Reddy's Share Price and Dr. Reddy's Stock Analysis are looking at a stock whose single-day move happened in a very large market-cap base. A 3.38% gain on a Rs 97,824 crore company naturally draws more attention than the same percentage move in a much smaller stock because it reflects a large change in equity value in absolute terms.

In Univest's framework, that keeps the focus on verifiable fundamentals: company size, category, and how the move fits inside the Healthcare market structure. To understand whether that structure makes the stock stand out further, it helps to compare the sector snapshot and peer set next.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	25.7x
Benchmark Average P/E	96.66x
Benchmark P/E Range	3.08x to 3,396.3x
Benchmark Median P/B	1.94x
Benchmark Median ROE	10.92%
Benchmark Median ROCE	13.38%
Company Market Capitalisation	Rs 97,824 crore
Benchmark Median Market Cap	Rs 142.3 crore

Dr. Reddy's Laboratories Ltd. (DRREDDY) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The sector context shows that Dr. Reddy's Share Price moved higher within a broad and diverse Healthcare universe, and the most important verified takeaway is that the company is dramatically larger than the benchmark population used here. That makes today's gain relevant not just as a price event but as a large-cap move inside a sector where many listed companies are far smaller.

The Healthcare sector snapshot covers 197 companies on a same sector benchmark basis. Within that universe, the median P/E is 25.70 and the average P/E is 96.66, based on 156 companies, with a range from 3.08 to 3,396.30. For P/B, the median is 1.94 and the average is 2.65 across 196 companies, with a range from -16.90 to 15.98. Profitability markers are also wide: median ROE is 10.92 and average ROE is 15.47 across 196 companies, while median ROCE is 13.38 and average ROCE is 17.78 across the same 196-company sample.

What the benchmark does show clearly is dispersion. This is not a tightly clustered sector where most companies trade or perform near one narrow band. Instead, the valuation and return ranges are broad, which means stock-specific analysis matters. Market-cap data underlines this point further. The median market capitalisation is Rs 142.30 crore, the average is Rs 472.15 crore, the minimum is Rs 4.08 crore, and the maximum listed in the benchmark set is Rs 3,032.97 crore. Against that backdrop, Dr. Reddy's market capitalisation of Rs 97,824 crore is in a completely different scale bracket.

For investors following Dr. Reddy's Share Price Today and Dr. Reddy's Latest News, the sector message is less about a generic healthcare narrative and more about positioning. This stock's rise occurred in a sector where benchmark valuations and returns vary sharply, but where the company's size places it well above the sample's central tendency. That makes today's move notable as one of the larger market-cap price rises within the Indian Stock Market's Healthcare space.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	0	0.76	-2.89	-0.26
Hikal Ltd.	HIKAL	2,799.54	0	2.32	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.09	9.77	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	66.92	10.59	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,601.85	34.14	7.04	-2.6	16.92

Dr. Reddy's Laboratories Ltd. (DRREDDY) has a market capitalisation of Rs 97,824 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The peer set reinforces just how different Dr. Reddy's Laboratories looks on size alone. The supplied listed peers include Dishman Carbogen Amcis at Rs 3,032.97 crore market capitalisation, Hikal at Rs 2,799.54 crore, Kwality Pharmaceuticals at Rs 2,707.20 crore, Beta Drugs at Rs 2,631.45 crore, and Dr Agarwals Eye Hospital at Rs 2,601.85 crore. Other peers in the supplied set include Panacea Biotec at Rs 2,531.49 crore, Sai Parenteral's at Rs 2,513.58 crore, Solara Active Pharma Sciences at Rs 2,422.79 crore, NGL Fine-Chem at Rs 2,118.60 crore, and Venus Remedies at Rs 2,068.61 crore.

Relative to those numbers, Dr. Reddy's market capitalisation of Rs 97,824 crore is vastly larger than every peer shown. That does not automatically make the stock better or worse, but it does mean comparisons should be interpreted carefully because the operating scale implied by the market value is very different. On valuation and return metrics, the peer set is varied. Kwality Pharmaceuticals shows a P/E of 40.09, Beta Drugs 66.92, Dr Agarwals Eye Hospital 34.14, Sai Parenteral's 181.97, NGL Fine-Chem 44.48, and Venus Remedies 17.49. P/B ratios range from 0.76 for Dishman Carbogen Amcis to 10.59 for Beta Drugs.

Profitability measures also vary widely. ROE spans from -2.89 for Dishman Carbogen Amcis and -2.60 for Dr Agarwals Eye Hospital to 28.21 for Kwality Pharmaceuticals and 27.90 for NGL Fine-Chem. ROCE ranges from -0.26 for Dishman Carbogen Amcis to 33.91 for NGL Fine-Chem. In short, the peer landscape is mixed on valuation and return metrics, while Dr. Reddy's most clearly differentiated supplied characteristic in this article is its much larger market capitalisation. For readers tracking Dr. Reddy's Company News and Momentum Analysis, today's share price rise therefore stands out primarily as a large-cap event rather than a move in a smaller peer-sized stock.

Why Investors Are Watching Dr. Reddy's Laboratories Ltd.

Investors are watching this stock because today's move combined a meaningful percentage gain with large-cap status. In market terms, that matters: a 3.38% rise in a company valued at Rs 97,824 crore is a more consequential market event than a similar move in a much smaller counter. It also occurred on active exchange participation, with total traded volume of 18,85,051 shares across BSE and NSE.

• Verified price action: Dr. Reddy's Share Price rose from the previous close of Rs 1,157.35 to Rs 1,196.50, after trading between Rs 1,155.20 and Rs 1,197.55.
• Category threshold:< 38% gain.
• Volume participation: Total volume stood at 18,85,051 shares, with 18,47,105 shares on NSE and 37,946 shares on BSE.
• Fundamental context: Market capitalisation of Rs 97,824 crore places the company far above the median and average size in the supplied Healthcare benchmark.
• Sector positioning: The Healthcare benchmark spans 197 companies with wide valuation and profitability dispersion, making stock-specific moves important to monitor.

What should investors monitor next? The most immediate points are whether Dr. Reddy's Share Price holds near its intraday high zone, whether future sessions sustain comparable trading activity, and whether the stock continues appearing among Top Gainers Today and Stocks Rising Today. Univest would also watch how this large-cap move evolves relative to the broader Healthcare peer universe rather than treating one session in isolation.

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. is being tracked here as a listed Healthcare company. The supplied dataset places it within the Healthcare sector and shows that it occupies a very large position by market capitalisation relative to the benchmark and peer set included in this article. With a market value of Rs 97,824 crore, it stands substantially above the sizes shown for the selected Healthcare peers and above the central tendency of the wider sector snapshot.

That positioning matters for readers looking at Dr. Reddy's Share Price Live, Dr. Reddy's Market Cap and Dr. Reddy's Share Price Update because large companies often influence sector-level attention differently from smaller names. In the benchmark universe of 197 Healthcare companies, the median market capitalisation is Rs 142.30 crore and the average is Rs 472.15 crore, while the maximum shown is Rs 3,032.97 crore. Dr. Reddy's is therefore operating in a market-value bracket that is far above the companies listed in the supplied comparison set.

For practical tracking purposes, that means the stock is best understood as a major large-cap Healthcare name within the Indian listed market rather than as a small niche play. Univest users following Dr. Reddy's Share Price, Dr. Reddy's News Today and Dr. Reddy's Stock Performance are therefore monitoring a stock whose size and price movement both matter in the daily market conversation.

Track Dr. Reddy's Share Price on Univest

Use Dr. Reddy's Laboratories Ltd. (DRREDDY) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Readers who want to follow Dr. Reddy's Share Price more closely can use Univest to track live share price movement, day range behaviour, 52-week levels, market-cap changes and broader market insights in one place. For stocks appearing in top gainer and market movers screens, keeping an eye on price action and context together is often more useful than looking at a headline move alone.

Univest helps users monitor Dr. Reddy's Share Price Today alongside key stock-market data points such as exchange-wise activity, sector context, peer comparisons and company-level market positioning. For investors who routinely follow Dr. Reddy's Stock News, Dr. Reddy's Share Price News and daily Market News, that makes it easier to see how a single-session rise fits into the broader listed-market picture without turning the update into a recommendation.

Frequently Asked Questions

Why is Dr. Reddy's Share Price in focus today?

Ans. Dr. Reddy's Share Price is in focus because it rose 3.38% to Rs 1,196.

What is Dr. Reddy's Share Price Today?

Ans. Dr. Reddy's Share Price Today was Rs 1,196.50 at the event timestamp. That was Rs 39.15 above the previous close of Rs 1,157.35, reflecting a same-day gain of 3.38% in the current trading session.

How much did Dr. Reddy's Laboratories stock rise today?

Ans. The stock rose by Rs 39.15 in absolute terms and 3.38% in percentage terms. That gain was enough to move Dr. Reddy's Laboratories into the large-cap price-rise screen being tracked in today's market update.

What were the day's high, low and opening levels?

Ans. Dr. Reddy's Laboratories opened at Rs 1,160.95, touched an intraday high of Rs 1,197.55 and a day low of Rs 1,155.20. The stock later traded near Rs 1,196.50, close to the upper end of that range.

What does the Large Cap threshold mean in this case?

Ans.< Since Dr. Reddy's Laboratories gained 3.38%, it cleared that bar and qualified for this price-rise event coverage.

How much trading volume was recorded in Dr. Reddy's stock?

Ans. Total traded volume stood at 18,85,051 shares, made up of 18,47,105 shares on NSE and 37,946 shares on BSE. The supplied BSE turnover figure was Rs 4.54 crore during the session covered in this article.

What is the market capitalisation of Dr. Reddy's Laboratories?

Ans. Dr. Reddy's Laboratories had a market capitalisation of Rs 97,824 crore in the supplied data. That places it firmly in the large-cap bracket and far above the benchmark Healthcare median market capitalisation of Rs 142.30 crore.

How does Dr. Reddy's compare with the Healthcare sector snapshot?

Ans. The Healthcare benchmark covers 197 companies, with a median market capitalisation of Rs 142.30 crore and an average of Rs 472.15 crore. Dr. Reddy's at Rs 97,824 crore is much larger than those sector reference levels.

Which peers are included in the comparison set?

Ans. The supplied peer set includes Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Dr Agarwals Eye Hospital, Panacea Biotec, Sai Parenteral's, Solara Active Pharma Sciences, NGL Fine-Chem and Venus Remedies, all with listed market metrics.

What should investors monitor after today's move?

Ans. Investors may monitor whether Dr. Reddy's Share Price holds near the day's high zone, whether volume remains elevated in coming sessions, and how the stock performs relative to Healthcare peers after this 3.38% large-cap gain.